Table 3 Prescription drug usage in CKD patients
CKD-related medication | CKD patients who took medication and did or did not see a nephrologsit (%), by stage | |||||||
|---|---|---|---|---|---|---|---|---|
Stage3a | Stage 3b | Stage 4 | Stage 5 | |||||
No | Yes | No | Yes | No | Yes | No | Yes | |
(n = 11,583) | (n = 2065) | (n = 3202) | (n = 1976) | (n = 378) | (n = 914) | (n = 14) | (n = 206) | |
RAS blocker | 6478 (55.9) | 1390 (67.3) | 1975 (61.7) | 1312 (66.4) | 204 (54.) | 516 (56.5) | 4 (28.6) | 89 (43.2) |
Aldosterone antagonist | 440 (3.8) | 252 (12.2) | 210 (6.6) | 276 (14.0) | 33 (8.7) | 111 (12.1) | 1 (7.1) | 5 (2.4) |
Phosphate binder | 4 (<0.1) | 26 (1.3) | 0 (0) | 71 (3.6) | 5 (1.3) | 157 (17.2) | 2 (14.3) | 120 (58.3) |
Vitamin D | 588 (5.1) | 256 (12.4) | 113 (3.5) | 291 (14.7) | 15 (4.0) | 272 (29.8) | 1 (7.1) | 78 (37.9) |
PPI | 3592 (31.0) | 810 (39.2) | 1087 (33.9) | 812 (41.1) | 140 (37.0) | 394 (43.1) | 3 (35.7) | 85 (41.3) |
ESA | 10 (0.1) | 39 (1.9) | 15 (0.5) | 88 (4.5) | 6 (1.6) | 123 (13.5) | 0 (0) | 38 (18.4) |
Loop diuretics | 2193 (18.9) | 809 (39.2) | 1029 (32.1) | 958 (48.5) | 147 (38.9) | 572 (62.6) | 4 (28.6) | 99 (48.1) |
Statin | 6056 (52.3) | 1249 (60.5) | 1721 (53.7) | 1197 (60.6) | 179 (47.4) | 539(59.0) | 5 (35.7) | 110 (5.4) |
NSAID | 2939 (25.4) | 492 (23.8) | 662 (20.7) | 392 (19.8) | 45 (11.9) | 125 (13.7) | 2 (14.3) | 11 (5.3) |